$4.84 Billion is the total value of Artal Group S.A.'s 70 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 58.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BUFF | BLUE BUFFALO PET PRODS INC | $2,683,809,000 | -9.0% | 114,987,547 | 0.0% | 55.40% | -3.7% | |
| LXRX | LEXICON PHARMACEUTICALS INC | $825,383,000 | +20.1% | 57,517,977 | 0.0% | 17.04% | +27.1% | |
| WW | WEIGHT WATCHERS INTL INC NEW | $342,426,000 | -20.0% | 29,443,300 | 0.0% | 7.07% | -15.3% | |
| GS | Buy | GOLDMAN SACHS GROUP INCcall | $185,725,000 | +18.3% | 1,250,000 | +25.0% | 3.83% | +25.2% |
| BAC | Buy | BANK AMER CORPcall | $66,350,000 | +9.1% | 5,000,000 | +11.1% | 1.37% | +15.4% |
| INCY | Buy | INCYTE CORP | $49,988,000 | +15.0% | 625,000 | +4.2% | 1.03% | +21.7% |
| REGN | Buy | REGENERON PHARMACEUTICALScall | $41,908,000 | +287.6% | 120,000 | +300.0% | 0.86% | +310.0% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $39,398,000 | +4.6% | 710,000 | +18.3% | 0.81% | +10.6% |
| WMT | WAL-MART STORES INCcall | $36,510,000 | +6.6% | 500,000 | 0.0% | 0.75% | +12.9% | |
| BIIB | Sell | BIOGEN INCcall | $36,273,000 | -65.2% | 150,000 | -62.5% | 0.75% | -63.1% |
| BABA | Buy | ALIBABA GROUP HLDG LTDsponsored ads | $31,812,000 | +7.3% | 400,000 | +6.7% | 0.66% | +13.7% |
| GS | GOLDMAN SACHS GROUP INC | $29,716,000 | -5.4% | 200,000 | 0.0% | 0.61% | +0.2% | |
| GOOGL | New | ALPHABET INCcall | $28,141,000 | – | 40,000 | +100.0% | 0.58% | – |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $27,230,000 | -17.5% | 350,000 | -12.5% | 0.56% | -12.7% |
| NKTR | Sell | NEKTAR THERAPEUTICS | $19,922,000 | -27.6% | 1,400,000 | -30.0% | 0.41% | -23.3% |
| MET | Sell | METLIFE INCcall | $19,915,000 | -39.6% | 500,000 | -33.3% | 0.41% | -36.1% |
| CELG | Sell | CELGENE CORPcall | $19,726,000 | -34.3% | 200,000 | -33.3% | 0.41% | -30.5% |
| BLUE | Sell | BLUEBIRD BIO INC | $19,481,000 | -8.3% | 450,000 | -10.0% | 0.40% | -3.1% |
| REGN | New | REGENERON PHARMACEUTICALS | $17,462,000 | – | 50,000 | +100.0% | 0.36% | – |
| 3106PS | DELPHI AUTOMOTIVE PLC | $17,215,000 | -16.6% | 275,000 | 0.0% | 0.36% | -11.7% | |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INCcall | $16,647,000 | +76.8% | 300,000 | +100.0% | 0.34% | +87.0% |
| KITE | Sell | KITE PHARMA INC | $16,250,000 | -27.0% | 325,000 | -33.0% | 0.34% | -22.8% |
| TSLA | New | TESLA MTRS INC | $15,921,000 | – | 75,000 | +100.0% | 0.33% | – |
| AGIO | Buy | AGIOS PHARMACEUTICALS INC | $15,711,000 | +15.5% | 375,000 | +11.9% | 0.32% | +22.3% |
| JPM | JPMORGAN CHASE & COcall | $15,535,000 | +4.9% | 250,000 | 0.0% | 0.32% | +11.1% | |
| IBM | New | INTERNATIONAL BUSINESS MACHScall | $15,178,000 | – | 100,000 | +100.0% | 0.31% | – |
| BAC | Buy | BANK AMER CORP | $14,597,000 | +8.0% | 1,100,000 | +10.0% | 0.30% | +14.0% |
| ARRY | Buy | ARRAY BIOPHARMA INC | $13,777,000 | +25.9% | 3,870,000 | +4.3% | 0.28% | +32.7% |
| VRTX | New | VERTEX PHARMACEUTICALS INCcall | $12,903,000 | – | 150,000 | +100.0% | 0.27% | – |
| USFD | New | US FOODS HLDG CORP | $12,120,000 | – | 500,000 | +100.0% | 0.25% | – |
| C | CITIGROUP INC | $10,598,000 | +1.5% | 250,000 | 0.0% | 0.22% | +7.4% | |
| MS | Sell | MORGAN STANLEY | $10,392,000 | -16.9% | 400,000 | -20.0% | 0.22% | -11.9% |
| MET | Buy | METLIFE INC | $9,958,000 | -3.6% | 250,000 | +6.4% | 0.21% | +2.5% |
| MCRB | Buy | SERES THERAPEUTICS INC | $9,006,000 | +50.7% | 310,000 | +37.8% | 0.19% | +59.0% |
| JUNO | Sell | JUNO THERAPEUTICS INC | $7,688,000 | -23.8% | 200,000 | -24.5% | 0.16% | -19.3% |
| FOLD | New | AMICUS THERAPEUTICS INC | $6,825,000 | – | 1,250,000 | +100.0% | 0.14% | – |
| SPNC | SPECTRANETICS CORP | $6,549,000 | +28.9% | 350,000 | 0.0% | 0.14% | +36.4% | |
| AVXS | Sell | AVEXIS INC | $6,155,000 | +29.1% | 161,900 | -7.5% | 0.13% | +36.6% |
| HZNP | New | HORIZON PHARMA PLC | $5,765,000 | – | 350,000 | +100.0% | 0.12% | – |
| CLLS | CELLECTIS S Asponsored ads | $5,584,000 | -3.3% | 210,000 | 0.0% | 0.12% | +1.8% | |
| JD | New | JD COM INCcall | $5,308,000 | – | 250,000 | +100.0% | 0.11% | – |
| NTLA | New | INTELLIA THERAPEUTICS INC | $4,804,000 | – | 225,000 | +100.0% | 0.10% | – |
| BLUE | New | BLUEBIRD BIO INCcall | $4,329,000 | – | 100,000 | +100.0% | 0.09% | – |
| NBIX | New | NEUROCRINE BIOSCIENCES INC | $4,318,000 | – | 95,000 | +100.0% | 0.09% | – |
| AGEN | Buy | AGENUS INC | $4,050,000 | +29.8% | 1,000,000 | +33.3% | 0.08% | +37.7% |
| RXDX | Buy | IGNYTA INC | $4,065,000 | +20.1% | 750,000 | +50.0% | 0.08% | +27.3% |
| CCXI | CHEMOCENTRYX INC | $4,041,000 | +80.3% | 900,000 | 0.0% | 0.08% | +88.6% | |
| RARE | New | ULTRAGENYX PHARMACEUTICAL IN | $3,668,000 | – | 75,000 | +100.0% | 0.08% | – |
| RDUS | New | RADIUS HEALTH INC | $3,675,000 | – | 100,000 | +100.0% | 0.08% | – |
| RDUS | New | RADIUS HEALTH INCcall | $3,675,000 | – | 100,000 | +100.0% | 0.08% | – |
| XLRN | New | ACCELERON PHARMA INC | $3,398,000 | – | 100,000 | +100.0% | 0.07% | – |
| BTX | BIOTIME INC | $3,346,000 | -9.1% | 1,282,050 | 0.0% | 0.07% | -4.2% | |
| SAGE | New | SAGE THERAPEUTICS INCcall | $3,013,000 | – | 100,000 | +100.0% | 0.06% | – |
| CLDX | CELLDEX THERAPEUTICS INC NEW | $2,963,000 | +16.1% | 675,000 | 0.0% | 0.06% | +22.0% | |
| IRWD | IRONWOOD PHARMACEUTICALS INC | $2,836,000 | +19.5% | 216,879 | 0.0% | 0.06% | +28.3% | |
| OPHT | New | OPHTHOTECH CORP | $2,552,000 | – | 50,000 | +100.0% | 0.05% | – |
| ONCE | New | SPARK THERAPEUTICS INC | $2,557,000 | – | 50,000 | +100.0% | 0.05% | – |
| GBT | New | GLOBAL BLOOD THERAPEUTICS IN | $2,074,000 | – | 125,000 | +100.0% | 0.04% | – |
| AGEN | AGENUS INCcall | $2,025,000 | -2.6% | 500,000 | 0.0% | 0.04% | +2.4% | |
| JUNO | Sell | JUNO THERAPEUTICS INCcall | $1,922,000 | -49.5% | 50,000 | -50.0% | 0.04% | -45.9% |
| SRPT | Sell | SAREPTA THERAPEUTICS INCcall | $1,907,000 | -51.2% | 100,000 | -50.0% | 0.04% | -48.7% |
| CEMP | New | CEMPRA INC | $1,649,000 | – | 100,000 | +100.0% | 0.03% | – |
| DMTX | DIMENSION THERAPEUTICS INC | $1,650,000 | -23.4% | 275,000 | 0.0% | 0.03% | -19.0% | |
| RGNX | Buy | REGENXBIO INC | $1,600,000 | -7.4% | 200,000 | +25.0% | 0.03% | -2.9% |
| AEGR | New | AEGERION PHARMACEUTICALS INC | $1,490,000 | – | 1,000,000 | +100.0% | 0.03% | – |
| NK | NANTKWEST INC | $1,400,000 | -24.3% | 225,000 | 0.0% | 0.03% | -19.4% | |
| CERE | CERES INC | $400,000 | +77.8% | 1,024,020 | 0.0% | 0.01% | +100.0% | |
| OCX | ONCOCYTE CORPORATION | $228,000 | -23.0% | 64,102 | 0.0% | 0.01% | -16.7% | |
| CLCD | COLUCID PHARMACEUTICALS INC | $46,000 | +31.4% | 5,575 | 0.0% | 0.00% | 0.0% | |
| PARNF | Exit | PARNELL PHARMACEUT HLDGS LTD | $0 | – | -500,000 | -100.0% | -0.02% | – |
| GLPI | Exit | GAMING & LEISURE PPTYS INC | $0 | – | -70,000 | -100.0% | -0.04% | – |
| PANW | Exit | PALO ALTO NETWORKS INC | $0 | – | -20,000 | -100.0% | -0.06% | – |
| AGIO | Exit | AGIOS PHARMACEUTICALS INCcall | $0 | – | -200,000 | -100.0% | -0.16% | – |
| LC | Exit | LENDINGCLUB CORP | $0 | – | -1,125,000 | -100.0% | -0.18% | – |
| DAL | Exit | DELTA AIR LINES INC DEL | $0 | – | -200,000 | -100.0% | -0.19% | – |
| JPM | Exit | JPMORGAN CHASE & CO | $0 | – | -200,000 | -100.0% | -0.23% | – |
| IONS | Exit | IONIS PHARMACEUTICALS INC | $0 | – | -350,000 | -100.0% | -0.28% | – |
| MA | Exit | MASTERCARD INCcl a | $0 | – | -200,000 | -100.0% | -0.37% | – |
| C | Exit | CITIGROUP INCcall | $0 | – | -500,000 | -100.0% | -0.41% | – |
| TEVA | Exit | TEVA PHARMACEUTICAL INDS LTDcall | $0 | – | -450,000 | -100.0% | -0.47% | – |
| CELG | Exit | CELGENE CORP | $0 | – | -360,000 | -100.0% | -0.70% | – |
| AAPL | Exit | APPLE INCcall | $0 | – | -400,000 | -100.0% | -0.85% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-08-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AGENUS INC | 42 | Q3 2023 | 1.9% |
| IRONWOOD PHARMACEUTICALS INC | 42 | Q3 2023 | 0.3% |
| ALNYLAM PHARMACEUTICALS INC | 37 | Q3 2023 | 5.1% |
| LEXICON PHARMACEUTICALS INC | 34 | Q3 2023 | 20.6% |
| AMICUS THERAPEUTICS INC | 30 | Q3 2023 | 2.7% |
| BEIGENE LTD | 28 | Q3 2023 | 7.4% |
| BK OF AMERICA CORP | 28 | Q1 2021 | 4.3% |
| SAGE THERAPEUTICS INC | 28 | Q2 2023 | 1.9% |
| AGIOS PHARMACEUTICALS INC | 28 | Q2 2020 | 1.1% |
| NEKTAR THERAPEUTICS | 27 | Q2 2020 | 1.3% |
View Artal Group S.A.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| WEIGHT WATCHERS INTERNATIONAL INC | February 13, 2015 | 29,443,300 | 51.9% |
View Artal Group S.A.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-25 |
| 4 | 2024-03-13 |
| 4 | 2024-02-29 |
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-13 |
| 4 | 2023-10-16 |
| 13F-HR | 2023-08-11 |
| 4 | 2023-06-22 |
| 3 | 2023-06-15 |
| 4 | 2023-06-05 |
View Artal Group S.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.